European Archives - Page 2 of 1280 - European Medical Journal

Obstructive Sleep Apnea Raises Risk of Brain Microbleeds

New research links Obstructive Sleep Apnea to brain microbleeds, suggesting early intervention could reduce neurological and stroke risks.

French Study Finds Higher Pregnancy Risks in Women With Systemic Sclerosis

French Study Finds Higher Pregnancy Risks in Women With Systemic Sclerosis

A large French cohort study finds that pregnant women with systemic sclerosis face increased risks of preeclampsia, preterm birth, and postpartum disease progression, underscoring the importance of close multidisciplinary care.

NHS Trials 15-Minute Blood Test to Fast-Track Diagnosis in Children

NHS hospitals are trialling a 15-minute blood test that quickly distinguishes viral and bacterial infections in children, allowing clinicians to detect sepsis or meningitis much faster.

chemotherapy

ASAP Trial Finds No Benefit for Pre-Transplant Chemotherapy in AML

The ASAP trial shows immediate transplantation matches chemotherapy outcomes in AML, with genetics driving survival differences.

HCV Incidence Falls as Scotland Nears WHO Target

HCV incidence among people who inject drugs in Scotland has halved since 2015, bringing WHO elimination targets within reach.

Low Pillow Height Linked to Throat Reflux in Patients With GORD

A new study finds that sleeping with a low pillow height significantly increases the risk of throat reflux in patients with GERD, suggesting that simple lifestyle changes like elevating the head during sleep may ease symptoms.

Stevens-Johnson Syndrome Therapy: Breakthrough Study

Recent research highlights programmed cell death mechanisms, apoptosis and necroptosis, as central to Stevens-Johnson syndrome and toxic epidermal necrolysis pathology.

Innovative, Automated Breathing Operator Developed for Preterm Infants

A new automated device, BOBBY, provides gentle tactile stimulation to help preterm infants breathe independently and reduce nurse intervention delays.

Enzalutamide Plus Leuprolide Boosts Survival Outcomes

After eight years, overall survival reached 78.9% in the combination group, compared with 69.5% among those receiving leuprolide alone.

Glucocorticoids Reduce Mortality in Community-Acquired Pneumonia

Adjunctive low-dose glucocorticoids lower 30-day mortality in adults with community-acquired pneumonia in low-resource hospital settings.